Stock Analiz

Vir Biotechnology, Inc. (VIR) stock forecast and price target

Price $9.96 · data as of November 13, 2026

12-month price target

Average target$23.38
Upside / downside+134.7%
Analysts8
ConsensusStrong buy
Low $17.00Average $23.38High $30.00

Gold marker: average target · white marker: today’s price ($9.96)

Analyst ratings

Strong buy 3Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.99+68.5%$330M
Next fiscal year
ends December 31, 2027
$-2.39−140.5%$67M
Next quarter
ends December 31, 2026
$-0.06+79.7%$87M
Quarter after
ends March 31, 2027
$-0.44+48.0%$17M

Consensus of the analysts covering Vir Biotechnology, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Vir Biotechnology stock price target?

The average 12-month target from 8 analysts is $23.38, 134.7% above the current price of $9.96 Targets range from $17.00 to $30.00.

Is Vir Biotechnology a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Vir Biotechnology expected to earn?

Analysts expect EPS of $-0.99 for the fiscal year ending December 31, 2026 and $-2.39 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.